Table 1.
Baseline demographics
| Total | Men (n = 391) | Women (n = 200) | p value | |
|---|---|---|---|---|
| Age, years | 50 ± 9 | 51 ± 9 | 48 ± 9 | 0.001 |
| Height, cm | 174.8 ± 13.7 | 179.3 ± 11.2 | 165.9 ± 13.7 | <0.001 |
| Weight, kg | 72.9 ± 13.0 | 78.6 ± 10.7 | 61.9 ± 9.8 | <0.001 |
| Body mass index, kg/m2 | 23.4 ± 3.6 | 22.4 ± 2.8 | 24.0 ± 3.8 | <0.001 |
| Marital status | ||||
| Married/committed relationship | 490/591 (82.9) | 349/391 (89.3) | 141/200 (70.5) | <0.001 |
| Single | 52/591 (8.8) | 24/391 (6.1) | 28/200 (14.0) | 0.001 |
| Divorced | 47/591 (8.0) | 18/391 (4.6) | 29/200 (14.5) | <0.001 |
| Children | 426/591 (72.1) | 314/391 (80.3) | 112/200 (56.0) | <0.001 |
| Religious | 200/591 (33.8) | 136/391 (34.8) | 64/200 (32.0) | 0.498 |
| Medication use | ||||
| Lipid lowering | 40/591 (6.8) | 35/391 (8.9) | 5/200 (2.5) | 0.003 |
| Antidepressants | 39/591 (6.6) | 14/391 (3.6) | 25/200 (12.5) | <0.001 |
| Blood pressure medications | 36/591 (6.1) | 26/391 (6.6) | 10/200 (5.0) | 0.427 |
| Thyroid replacement therapy | 34/591 (5.8) | 12/391 (3.1) | 22/200 (11.0) | <0.001 |
| Aspirin/anticoagulants | 30/391 (5.1) | 26/391 (6.6) | 4/200 (2.0) | 0.003 |
| Pain medications | 19/591 (3.2) | 11/391 (2.8) | 8/200 (4.0) | 0.465 |
| Asthma/allergy | 19/591 (3.2) | 10/391 (2.6) | 9/200 (4.5) | 0.223 |
| Othera | 18/591 (3.0) | 11/391 (2.8) | 7/200 (3.5) | 0.622 |
| OC/hormone replacement therapy | 10/591 (1.7) | 0/391 (0.0) | 10/200 (5.0) | N/A |
| BPH medications/sildenafil | 5/591 (0.8) | 5/391 (1.3) | 0/200 (0.0) | N/A |
| Arrhythmia drugs | 3/591 (0.5) | 2/391 (0.5) | 1/200 (0.5) | 1.000 |
Values are mean ± SD or n (%); p values reflect significance of difference between men and women
BPH benign prostatic hyperplasia, OC oral contraceptive, N/A not applicable
aIncludes allopurinol, antiseizure, biologics, and immunosuppressants